Skip to Content

Methocarbamol Tablets

Last Updated: August 7, 2020
Status: Resolved

Products Affected - Description
    • Robaxin oral tablet, Endo Pharmaceuticals, 500 mg, bottle, 100 count, NDC 52244-0429-10 - discontinued
    • Robaxin oral tablet, Endo Pharmaceuticals, 750 mg, bottle, 100 count, NDC 52244-0449-10 - discontinued
    • Methocarbamol oral tablet, Par Pharmaceuticals, 500 mg, bottle, 100 count, NDC 00603-4485-21 - discontinued
    • Methocarbamol oral tablet, Par Pharmaceuticals, 500 mg, bottle, 500 count, NDC 00603-4485-28 - discontinued
    • Methocarbamol oral tablet, Par Pharmaceuticals, 750 mg, bottle, 100 count, NDC 00603-4486-21 - discontinued
    • Methocarbamol oral tablet, Par Pharmaceuticals, 750 mg, bottle, 500 count, NDC 00603-4486-28 - discontinued
    • Methocarbamol oral tablet, Par Pharmaceuticals, 750 mg, bottle, 1000 count, NDC 00603-4486-32 - discontinued
    • Methocarbamol oral tablet, Virtus, 500 mg, bottle, 100 count, NDC 69543-0134-10 - discontinued
    • Methocarbamol oral tablet, Virtus, 500 mg, bottle, 500 count, NDC 69543-0134-50 - discontinued
    • Methocarbamol oral tablet, Virtus, 750 mg, bottle, 100 count, NDC 69543-0135-10 - discontinued
    • Methocarbamol oral tablet, Virtus, 750 mg, bottle, 500 count, NDC 69543-0135-50 - discontinued
Reason for the Shortage
    • Bayshore has methocarbamol tablets available.
    • Camber has methocarbamol tablets available.
    • Endo discontinued Robaxin tablets in January 2020.
    • Granules has methocarbamol tablets available.
    • Hikma is not actively marketing methocarbamol tablets.
    • Par discontinued methocarbamol tablets in July 2018.
    • Solco states the shortage was due to an active ingredient shortage.
    • Virtus discontinued methocarbamol tablets in June 2019.
Available Products
    • Methocarbamol oral tablet, Bayshore, 500 mg, bottle, 100 count, NDC 76385-0123-01
    • Methocarbamol oral tablet, Bayshore, 500 mg, bottle, 500 count, NDC 76385-0123-50
    • Methocarbamol oral tablet, Bayshore, 750 mg, bottle, 100 count, NDC 76385-0124-01
    • Methocarbamol oral tablet, Bayshore, 750 mg, bottle, 500 count, NDC 76385-0124-50
    • Methocarbamol oral tablet, Camber, 500 mg, bottle, 100 count, NDC 31722-0533-01
    • Methocarbamol oral tablet, Camber, 500 mg, bottle, 500 count, NDC 31722-0533-05
    • Methocarbamol oral tablet, Camber, 750 mg, bottle, 100 count, NDC 31722-0534-01
    • Methocarbamol oral tablet, Camber, 750 mg, bottle, 500 count, NDC 31722-0534-05
    • Methocarbamol oral tablet, Granules, 500 mg, bottle, 100 count, NDC 62207-0754-43
    • Methocarbamol oral tablet, Granules, 500 mg, bottle, 500 count, NDC 62207-0754-47
    • Methocarbamol oral tablet, Granules, 750 mg, bottle, 100 count, NDC 62207-0770-43
    • Methocarbamol oral tablet, Granules, 750 mg, bottle, 500 count, NDC 62207-0770-47
    • Methocarbamol oral tablet, Solco Healthcare US, 500 mg, bottle, 100 count, NDC 43547-0405-10
    • Methocarbamol oral tablet, Solco Healthcare US, 500 mg, bottle, 500 count, NDC 43547-0405-50
    • Methocarbamol oral tablet, Solco Healthcare US, 750 mg, bottle, 100 count, NDC 43547-0226-10
    • Methocarbamol oral tablet, Solco Healthcare US, 750 mg, bottle, 500 count, NDC 43547-0226-50

Updated

Updated August 7, 2020 by Leslie Jensen, PharmD, Drug Information Specialist. Created May 8, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.